๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Effect of the aldose reductase inhibitor fidarestat on experimental diabetic neuropathy in the rat

โœ Scribed by Y. Kuzumoto; S. Kusunoki; N. Kato; M. Kihara; P. A. Low

Publisher
Springer
Year
2006
Tongue
English
Weight
338 KB
Volume
49
Category
Article
ISSN
0012-186X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Clinical and neurophysiological studies
Clinical and neurophysiological studies with the aldose reductase inhibitor, sorbinil, in symptomatic diabetic neuropathy
โœ I. G. Lewin; I. A. D. O'Brien; M. H. Morgan; R. J. M. Corrall ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› Springer ๐ŸŒ English โš– 436 KB

The effect of sorbinil (200 mg daily for 4 weeks) was examined in 13 patients, mean age 59.7 years (range 42-72 years), with symptomatic diabetic neuropathy of mean duration 6 year (range 1-18 years). In this double-blind, placebo-controlled crossover trial, studies were made of motor, sensory and a

The effect of aldose reductase inhibitor
The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus
โœ W. P. Chang; E. Dimitriadis; T. Allen; M. E. Dunlop; M. Cooper; R. G. Larkins ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Springer ๐ŸŒ English โš– 742 KB

The effect of two structurally unrelated aldose reductase inhibitors, sorbinil and ponalrestat, on glomerular prostaglandin production and urinary albumin excretion was investigated in rats with diabetes induced by streptozotocin. It was found that both aldose reductase inhibitors, when administered